TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cybin ( (TSE:CYBN) ) has issued an update.
On September 2, 2025, Cybin Inc. announced a significant leadership change with Doug Drysdale stepping down as CEO. Eric So, the company’s Co-Founder and President, has been appointed as Interim CEO. The Board of Directors has initiated a search for a new CEO to lead the company through its commercialization phase, emphasizing its commitment to advancing mental healthcare solutions.
The most recent analyst rating on (TSE:CYBN) stock is a Buy with a C$150.00 price target. To see the full list of analyst forecasts on Cybin stock, see the TSE:CYBN Stock Forecast page.
Spark’s Take on TSE:CYBN Stock
According to Spark, TipRanks’ AI Analyst, TSE:CYBN is a Underperform.
Cybin’s stock score is significantly impacted by its lack of revenue and continuous financial losses, resulting in a low valuation score. While technical indicators are neutral, positive corporate events indicate potential for future growth. However, current financial challenges remain the dominant concern.
To see Spark’s full report on TSE:CYBN stock, click here.
More about Cybin
Cybin Inc. operates in the mental healthcare industry, focusing on developing innovative next-generation treatment options for patients. The company is involved in the commercialization of new therapies aimed at revolutionizing mental healthcare.
Technical Sentiment Signal: Hold
Current Market Cap: C$1.97M
See more data about CYBN stock on TipRanks’ Stock Analysis page.